Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety of Intramuscular HBIG Grifols for the Prevention of Recurrence After Liver Transplantation

This study has been completed.
Sponsor:
Information provided by:
Grifols Biologicals Inc.
ClinicalTrials.gov Identifier:
NCT00895713
First received: May 7, 2009
Last updated: NA
Last verified: May 2009
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2005
  Primary Completion Date: June 2005 (Final data collection date for primary outcome measure)